Prévia do material em texto
Leitura obrigatória 1. Instituto para Práticas Seguras no Uso de Medicamentos. Desafio Global de Segurança do Paciente – Medicação sem danos [Internet]. Boletim ISMP Brasil. 2018;7(1):1-8. [acesso em junho 2023]. Disponível em: https://www.ismp- brasil.org/site/wp-content/uploads/2018/02/ISMP_Brasil_Desafio_Global.pdf 2. World Health Organization. (2019). Medication safety in polypharmacy: technical report. World Health Organization. https://apps.who.int/iris/handle/10665/325454. Licença: CC BY-NC-SA 3.0 IGO 3. World Health Organization. (2019). Medication safety in transitions of care: technical report. World Health Organization. https://apps.who.int/iris/handle/10665/325453. Licença: CC BY-NC-SA 3.0 IGO 4. World Health Organization. (2019). Medication safety in high-risk situations. World Health Organization. https://apps.who.int/iris/handle/10665/325131. Licença: CC BY-NC-SA 3.0 IGO 5. Instituto para Práticas Seguras no Uso de Medicamentos. Polifarmácia: Quando muito é demais? [Internet]. Boletim ISMP Brasil. 2018;7(3):1-8. [acesso em junho 2023]. Disponível em: https://www.ismp-brasil.org/site/wp- content/uploads/2018/12/BOLETIM-ISMP-NOVEMBRO.pdf 6. Instituto para Práticas Seguras no Uso de Medicamentos. Medicamentos potencialmente perigosos de uso ambulatorial e para instituições de longa permanência - listas atualizadas 2022 [Internet]. Boletim ISMP Brasil. 2022;11(1):1-9. [acesso em junho 2023]. Disponível em: https://www.ismp- brasil.org/site/wp-content/uploads/2022/09/MEDICAMENTOS- POTENCIALMENTE-PERIGOSOS-LISTAS-ATUALIZADAS-2022.pdf 7. Instituto para Práticas Seguras no Uso de Medicamentos. Medicamentos potencialmente perigosos de uso hospitalar - lista atualizada 2019 [Internet]. Boletim ISMP Brasil. 2019;8(1):1-9. [acesso em junho 2023]. Disponível em: https://www.ismp-brasil.org/site/wp-content/uploads/2019/02/BOLETIM-ISMP- FEVEREIRO-2019.pdf 8. Instituto para Práticas Seguras no Uso de Medicamentos. Uso seguro de medicamentos por pacientes com doença renal crônica [Internet]. Boletim ISMP Brasil. 2021;10(5):1-10. [acesso em junho 2023]. Disponível em: https://www.ismp-brasil.org/site/wp- content/uploads/2021/10/Boletim_outubro_2021_doenca_renal_cronica.pdf 9. Instituto para Práticas Seguras no Uso de Medicamentos. Prevenção de erros de medicação na transição do cuidado [Internet]. Boletim ISMP Brasil. 2019;8(2):1- 11. [acesso em junho 2023]. Disponível em: https://www.ismp-brasil.org/site/wp- content/uploads/2019/04/boletim_ismp_30a_edicao.pdf 10. Instituto para Práticas Seguras no Uso de Medicamentos. Estratégias para envolver o paciente na prevenção de erros de medicação [Internet]. Boletim ISMP Brasil. 2019;8(3):1-9. [acesso em junho 2023]. Disponível em: https://www.ismp- brasil.org/site/wp- content/uploads/2019/05/Estrategias_para_envolver_o_paciente_Boletim_ISMP_ Brasil.pdf https://www.ismp-brasil.org/site/wp-content/uploads/2018/02/ISMP_Brasil_Desafio_Global.pdf https://www.ismp-brasil.org/site/wp-content/uploads/2018/02/ISMP_Brasil_Desafio_Global.pdf https://apps.who.int/iris/handle/10665/325454 https://apps.who.int/iris/handle/10665/325453 https://apps.who.int/iris/handle/10665/325131 https://www.ismp-brasil.org/site/wp-content/uploads/2018/12/BOLETIM-ISMP-NOVEMBRO.pdf https://www.ismp-brasil.org/site/wp-content/uploads/2018/12/BOLETIM-ISMP-NOVEMBRO.pdf https://www.ismp-brasil.org/site/wp-content/uploads/2022/09/MEDICAMENTOS-POTENCIALMENTE-PERIGOSOS-LISTAS-ATUALIZADAS-2022.pdf https://www.ismp-brasil.org/site/wp-content/uploads/2022/09/MEDICAMENTOS-POTENCIALMENTE-PERIGOSOS-LISTAS-ATUALIZADAS-2022.pdf https://www.ismp-brasil.org/site/wp-content/uploads/2022/09/MEDICAMENTOS-POTENCIALMENTE-PERIGOSOS-LISTAS-ATUALIZADAS-2022.pdf https://www.ismp-brasil.org/site/wp-content/uploads/2019/02/BOLETIM-ISMP-FEVEREIRO-2019.pdf https://www.ismp-brasil.org/site/wp-content/uploads/2019/02/BOLETIM-ISMP-FEVEREIRO-2019.pdf https://www.ismp-brasil.org/site/wp-content/uploads/2021/10/Boletim_outubro_2021_doenca_renal_cronica.pdf https://www.ismp-brasil.org/site/wp-content/uploads/2021/10/Boletim_outubro_2021_doenca_renal_cronica.pdf https://www.ismp-brasil.org/site/wp-content/uploads/2019/04/boletim_ismp_30a_edicao.pdf https://www.ismp-brasil.org/site/wp-content/uploads/2019/04/boletim_ismp_30a_edicao.pdf https://www.ismp-brasil.org/site/wp-content/uploads/2019/05/Estrategias_para_envolver_o_paciente_Boletim_ISMP_Brasil.pdf https://www.ismp-brasil.org/site/wp-content/uploads/2019/05/Estrategias_para_envolver_o_paciente_Boletim_ISMP_Brasil.pdf https://www.ismp-brasil.org/site/wp-content/uploads/2019/05/Estrategias_para_envolver_o_paciente_Boletim_ISMP_Brasil.pdf https://www.ismp-brasil.org/site/wp-content/uploads/2019/05/Estrategias_para_envolver_o_paciente_Boletim_ISMP_Brasil.pdf Leitura complementar sugerida 1. MIRA JJ et al. A systematic review of patient medication error on self-administering medication at home. Expert Opin Drug Saf 2015;14(6):815–38. 2. Cadogan CA, Ryan C, Hughes CM. Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many. Drug Saf 2016;39:109–16. 3. Lee EA et al. Refining the Definition of Polypharmacy and Its Link to Disability in Older Adults: Conceptualizing Necessary Polypharmacy, Unnecessary Polypharmacy, and Polypharmacy of Unclear Benefit. The Permanente journal 2020;24(18):1-6. 4. Pazan F, Wehling M. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences. European geriatric medicine 2021;12(3):443–52. 5. American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023 May 4. doi: 10.1111/jgs.18372. 6. Morin L et al. Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: a European expert consensus. Eur J Clin Pharmacol 2018;74:1333–42. 7. Lindsay J et al. The development and evaluation of an oncological palliative care deprescribing guideline: the 'OncPal deprescribing guideline'. Support Care Cancer. 2015 Jan;23(1):71-8. 8. Thompson J. Deprescribing in palliative care. Clin Med (Lond). 2019 Jul;19(4):311- 4. 9. Hedman C, Frisk G, Björkhem-Bergman L. Deprescribing in Palliative Cancer Care. Life. 2022; 12(5):613. 10. Souza BG et al. Eventos adversos a medicamentos entre idosos no Brasil antes e após o início da pandemia da COVID-19. Vigil Sanit Debate 2022;10(3):13-21. 11. Zulman DM et al. Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med. 2011 Jul;26(7):783-90. 12. Kochar B et al. Systematic Review of Inclusion and Analysis of Older Adults in Randomized Controlled Trials of Medications Used to Treat Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2021 Aug 19;27(9):1541-1543. 13. PageII RL et al. Drugs That May Cause or Exacerbate Heart Failure. Circulation 2016;134(6): e32–e69. 14. Verbeeck RK. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol 2008;64:1147–61. 15. Knight DA et al. ‘Seamless care? Just a list would have helped!’ Older people and their carer’s experiences of support with medication on discharge home from hospital. Health Expectations 2011;16(3):277-91. 16. Sawan MJ et al. Caregivers' experiences of medication management advice for people living with dementia at discharge. Journal of Evaluation in Clinical Practice 2021;27(6):1252-61. 17. Schlögl M et al. Communication during the COVID-19 pandemic: evaluation study on self-perceived competences and views of health care professionals. Eur Geriatr Med. 2021 Dec;12(6):1181-90. 18. Pantuzza LLN et al. Mapping the construct and measurement of medication literacy: a scoping review. Br J Clin Pharmacol. 2021;87:754–75.19. Neiva Pantuzza LL et al. Medication literacy: A conceptual model. Res Social Adm Pharm. 2022 Apr;18(4):2675-82. 20. Pantuzza LLN et al. Development and content validation of the medication literacy test for older adults (TELUMI), Archives of Gerontology and Geriatrics 023 Sep;112:105027. 21. Rezende CP et al. Family caregivers’ experience in the process of caring for older adults: a qualitative synthesis. RESEARCH, SOCIETY AND DEVELOPMENT 2021;10:e27101220037. 22. Cruzeiro MGM et al. Experience in caring for the older people with dementia in the home environment: a qualitative synthesis of evidence. Revista de Pesquisa: Cuidado é Fundamental (Online) 2022;14:1-9. Leitura obrigatória